SU&K Partner Scharf Speaks at 50th Annual FDLI and FDA Conference

Partner Stephanie Scharf was an invited speaker at the Food and Drug Law Institute’s FDA Conference in Bethesda, Maryland, on April 13, 2007.  As a member of the panel speaking on Drug and Device Co-Development, Ms. Scharf’s presentation addressed Litigation Risk Management Strategies in the context of FDA-regulated “combination products.”  Other members of the panel, including James S. Cohen, Food and Drug Administration; Andrea E. Chamblee, Otsuka Maryland Research Institute; and Steven B. Binion, Ph.D., BD Technologies, addressed the regulatory aspects of co-development and marketing activities for combined products.  Please contact Ms. Scharf if you are interested in receiving a copy of her presentation.